Navigating MIBC management: Integrating ctDNA into clinical practice
Date: Monday, July 20, 2026
Time: 5:00 - 5:45 PM ET (45-minute webinar)
Registrants will receive a recording of the webinar approximately one week after the event.
Join Michael Adashek, DO, medical oncologist, hematologist, and Director of GU Medical Oncology at Chesapeake Urology, for a live, case-based webinar designed for urologists.
This session will explore how ctDNA testing may provide additional insight across key MIBC decision points, including:
Dr. Adashek will review practical patient cases and discuss relevant clinical data, including IMvigor011 and NIAGARA, to help illustrate how ctDNA may support multidisciplinary MIBC management.